RUNX3 and cancer: The frequent epigenetic inactivation of RUNX3 in cancer [8] and the paradoxical elevated RUNX3 expression in metastatic pancreatic cancer [36] indicate that tight control of RUNX3’s activities are crucial for normal growth.